GC
INSM icon

Guggenheim Capital’s Insmed INSM Stock Holding History

Guggenheim Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13M Sell
38,766
-41,255
-52% -$5M 0.03% 499
2026
Q1 		$13.1M Sell
80,021
-2,270
-3% -$349K 0.1% 217
2025
Q4 		$14.3M Buy
82,291
+45,431
+123% +$8.29M 0.1% 200
2025
Q3 		$5.31M Sell
36,860
-4,531
-11% -$555K 0.04% 423
2025
Q2 		$4.17M Buy
41,391
+5,945
+17% +$455K 0.03% 470
2025
Q1 		$2.7M Buy
35,446
+1,104
+3% +$84.5K 0.02% 560
2024
Q4 		$2.37M Sell
34,342
-2,963
-8% -$213K 0.02% 597
2024
Q3 		$2.72M Buy
37,305
+805
+2% +$59.4K 0.02% 721
2024
Q2 		$2.45M Sell
36,500
-14,192
-28% -$550K 0.02% 745
2024
Q1 		$1.38M Buy
50,692
+6,682
+15% +$187K 0.01% 1047
2023
Q4 		$1.36M Sell
44,010
-7,908
-15% -$205K 0.01% 1009
2023
Q3 		$1.31M Sell
51,918
-8,661
-14% -$198K 0.01% 980
2023
Q2 		$1.28M Sell
60,579
-2,258
-4% -$42.8K 0.01% 1048
2023
Q1 		$1.07M Buy
+62,837
New +$1.22M 0.01% 1147
2018
Q2 		– Sell
-103,962
Closed -$2.34M – 2486
2018
Q1 		$2.34M Buy
103,962
+8,183
+9% +$215K 0.01% 1520
2017
Q4 		$2.99M Buy
+95,779
New +$2.83M 0.01% 1364
2014
Q4 		– Sell
-173,377
Closed -$2.26M – 3056
2014
Q3 		$2.26M Buy
173,377
+71,366
+70% +$1.08M 0.01% 1673
2014
Q2 		$2.04M Buy
+102,011
New +$1.51M 0.01% 1808
2013
Q3 		– Sell
-10,671
Closed -$128K – 3114
2013
Q2 		$128K Buy
+10,671
New +$109K ﹤0.01% 2798

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Guggenheim Capital's INSM Position: Q2 2026 in Review

Guggenheim Capital reduced its Insmed (INSM) stake by 52% in Q2 2026, selling an estimated $5M and leaving 38,766 shares worth $4.13M. The position accounts for 0.03% of the portfolio, ranked #499.

Guggenheim Capital first reported a position in INSM in Q2 2013 and has held it in 19 quarters since. The position peaked at $14.3M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Guggenheim Capital held 38,766 shares of Insmed worth $4.13M as of Q2 2026.
  • Guggenheim Capital sold 41,255 Insmed shares in Q2 2026, an estimated $5M.
  • Insmed made up 0.03% of Guggenheim Capital's portfolio in Q2 2026, its #499 holding.
  • Guggenheim Capital first reported a position in Insmed in Q2 2013 and has held it in 19 quarters since.
  • Guggenheim Capital's Insmed position peaked at $14.3M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.